Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Dexamethasone Doses for Supraclavicular Block in AV Fistula Creation
NCT06389617Not yet recruiting
- Sponsor
- Hospital Universiti Sains Malaysia
- Start
- May 2024
- Primary completion
- Nov 2024
- Modality
- Orthosteric Ligands
01
Overview
Randomised trial of dexamethasone in end stage renal disease (ESRD) (2 arms), sponsored by Hospital Universiti Sains Malaysia. Primary endpoints: Onset time of sensory block at 2 days, Onset time of motor block at 2 days and 1 more. Planned start May 2024; status: not yet recruiting.
02
Drugs
dexamethasone
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT06389617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06389617.